|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
19 February 2015 |
|
Main ID: |
NCT02327819 |
|
Date of registration:
|
24/12/2014 |
|
Prospective Registration:
|
Yes |
|
Primary sponsor: |
|
|
Public title:
|
The Effect of Branched-chain Amino Acid (BCAA) on the Progression of Primary Liver Cancer
|
|
Scientific title:
|
|
|
Date of first enrolment:
|
January 2015 |
|
Target sample size:
|
60 |
|
Recruitment status: |
Not yet recruiting |
|
URL:
|
http://clinicaltrials.gov/show/NCT02327819 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator)
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
Israel
| | | | | | | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- diagnosed primary liver cancer
- viral or Nonalcoholic Steatohepatitis Cirrhosis
- Cirrhosis rated Child-Pugh A
- liver cancer rated Barcelona Clinic Liver Cancer (BCLC) A
Exclusion Criteria:
- Age (over 65)
- liver condition rated Child-Pugh B/C
- GI/Absorption issues
- patients given a treatment before surgery
Age minimum:
18 Years
Age maximum:
65 Years
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Primary Liver Cancer
|
|
Intervention(s)
|
|
Dietary Supplement: Branched-chain amoni acids (BCAA)
|
|
Dietary Supplement: non-BCAA protein supplement
|
|
Primary Outcome(s)
|
|
time until a new liver tumor is found
[Time Frame: 2 years]
|
|
Secondary ID(s)
|
|
0440-14-TLV
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|